Loading…

Flash Player 9 (or above) is needed to view presentations.
We have detected that you do not have it on your computer. To install it, go here.

Like this document? Why not share!

medschool.umaryland.edu

on

  • 950 views

 

Statistics

Views

Total Views
950
Views on SlideShare
950
Embed Views
0

Actions

Likes
0
Downloads
1
Comments
0

0 Embeds 0

No embeds

Accessibility

Categories

Upload Details

Uploaded via as Microsoft Word

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

    medschool.umaryland.edu medschool.umaryland.edu Document Transcript

    • CURRICULUM VITAE Mohan Suntharalingam, MD The Marlene and Stewart Greenebaum Professor of Radiation Oncology University of Maryland School of Medicine DATE: January 1, 2007 OFFICE ADDRESS University of Maryland School of Medicine Department of Radiation Oncology 22 S. Greene Street, GGK0101 Baltimore, MD 21201 E-mail: msuntha@umm.edu (410) 328-2331 (410) 328-6911 fax CURRENT ADMINISTRATIVE ROLE Vice Chairman/Clinical Director Department of Radiation Oncology Professor, University of Maryland School of Medicine Associate Director of Clinical Affairs University of Maryland Marlene and Stewart Greenebaum Cancer Center Director - Program of Excellence in Technology Based Translational Research Department of Radiation Oncology University of Maryland School of Medicine EDUCATION 1982 - 1986 A.B. – Human Biology (Biology & Psychology) – Brown University Providence, Rhode Island 1986 - 1990 M.D. – Jefferson Medical College – Philadelphia, PA POST GRADUATE TRAINING 1990 – 1991 Internship in Internal Medicine, Bryn Mawr Hospital Bryn Mawr, Pennsylvania 1991 – 1993 Resident in the Department of Radiation Oncology University of Maryland Medical Systems – Baltimore, MD 1993 – 1994 Chief Resident in the Department of Radiation Oncology University of Maryland Medical Systems – Baltimore, MD 1994 – 1995 Clinical Oncology Fellow of the American Cancer Society University of Maryland Medical Systems – Baltimore, MD 1
    • SUB-SPECIALTY ROTATION DURING RESIDENCY TRAINING 1/93 Breast Service, Department of Radiation Oncology Thomas Jefferson University Hospital Philadelphia, PA 3/94 Head and Neck Service, Department of Radiation Oncology University of Florida, Gainesville, FL 5/94 Pediatric Service, Department of Radiation Oncology St. Jude Children’s Research Hospital Memphis, TN 3/95 Conformal Therapy Research Program Christie Hospital, Manchester, England Royal Marsden Hospital, London, England CERTIFICATION 6/91 Diplomat of the National Board of Medical Examiner 6/95 Certification in Radiation Oncology by the American Board of Radiology 5/05 Re-Certification in Radiation Oncology by the American Board of Radiology LICENSE Maryland License #: D0047618 FACULTY APPOINTMENTS 7/95 – 6/01 Assistant Professor Department of Radiation Oncology University of Maryland School of Medicine 7/01 – 6/04 Associate Professor Department of Radiation Oncology University of Maryland School of Medicine 7/04 – 7/06 Associate Professor with Tenure Department of Radiation Oncology University of Maryland School of Medicine 7/06 – Present Professor with Tenure Department of Radiation Oncology University of Maryland School of Medicine 2
    • ADMINISTRATIVE APPOINTMENTS 8/97 – Present Vice Chairman Department of Radiation Oncology University of Maryland School of Medicine 1/03 – 1/06 Associate Director for Multidisciplinary Program Development and Outreach University of Maryland Marlene and Stewart Greenebaum Cancer Center 1/06 – Present Associate Director of Clinical Affairs, University of Maryland Marlene and Stewart Greenebaum Cancer Center 7/06 – Present Director Program of Excellence in Technology Based Translational Research Department of Radiation Oncology University of Maryland School of Medicine (Direct oversight of a planned $5million endowed research program) CLINICAL APPOINTMENTS 7/95 – Present Member, Program in Oncology University of Maryland Marlene and Stewart Greenebaum Cancer Center 10/95 – 8/97 Acting Clinical Director Department of Radiation Oncology University of Maryland School of Medicine 8/97 – Present Clinical Director Department of Radiation Oncology University of Maryland School of Medicine 6/02 – Present Medical Director Department of Radiation Oncology Baltimore Washington Medical Center 1/03 – Present Director of Clinical/Translational Research Department of Radiation Oncology University of Maryland School of Medicine PROFESSIONAL MEMBERSHIPS • 1986 – Present The Omega Psi Phi Fraternity • 1991 – 1995 American Medical Association Member • 1991 – 1995 Association of Residents in Radiation Oncology • 1991 – Present American College of Radiation Oncology • 1991 – Present American Society for Therapeutic Radiology and Oncology • 1995 – Present Simon Kramer Society (Vice Chairman) 3
    • • 1997 – Present Radiation Therapy Oncology Group • 2000 American College of Radiology • 2000 American Radium Society AWARDS & HONORS • 1988 – 1990 Amory Hare Medical Honor Society • 1995 Clinical Oncology Fellowship in Conformal Therapy, sponsored by The American College of Radiation Oncology • 1999 Nominated for the Lane W. Adams Award sponsored by the American Cancer Society • 2005 Best Doctors in America, Best Doctors, Inc. • 2006 Endowed Professorship, University of Maryland Marlene and Stewart Greenebaum Cancer Center INSTITUTIONAL COMMITTEES 1996 Member – CALGB Clinical Research Committee University of Maryland Marlene and Stewart Greenebaum Cancer Center 1996 Member – Oncology Network Development and Implementation Team University of Maryland Medical Center 1997 Member – Clinical Productivity Design Team Office of the Dean, University of Maryland at Baltimore 1996 - 1997 Member – Search Committee, Deputy Director for Clinical Affairs University of Maryland Marlene and Stewart Greenebaum Cancer Center 1996 - 1999 Director, Esophageal Cancer Section, Thoracic Malignancy Task Force University of Maryland Marlene and Stewart Greenebaum Cancer Center 1996 - Present Member – University of Maryland School of Medicine Council 1996 - Present Member – Clinical Research Committee University of Maryland Marlene and Stewart Greenebaum Cancer Center 1996 - Present Member – Cancer Committee, University of Maryland Marlene and Stewart Greenebaum Cancer Center 1996 - 2000 Member, Baltimore VA Medical Center Cancer Committee 1996 - 2000 Member – Total Body Irradiation Task Force Department of Radiation Oncology University of Maryland School of Medicine 1998 - Present Member – Cancer Review Committee 4
    • University of Maryland Marlene and Stewart Greenebaum Cancer Center 1998 - Present Physician Compliance Liaison, Department of Radiation Oncology, University of Maryland School of Medicine 1999 - 2002 Montgomery General Hospital Radiation Oncology Center Development Group INSTITUTIONAL COMMITTEES – Continued 2000 - 2002 Member - North Arundel Hospital Radiation Oncology Center Development Group 2002 Member – Dean’s Search Committee for Position of Chairman of the Department of Radiology, University of Maryland School of Medicine 2002 - Present Member – Cancer Center Research Council University of Maryland Marlene and Stewart Greenebaum Cancer Center 2002 Member – Cancer Council Unversity of Maryland Marlene and Stewart Greenebaum Cancer Center 2003 Member – Dean’s Search Committee for Position of Chairman of the Department of Otolaryngology, University of Maryland School of Medicine 2003 - Present Member – Bicentennial Planning Committee, University of Maryland School of Medicine 2004 - Present Member – Ambulatory Care Project Opening Group University of Maryland Medical Center 2007 LCME Institutional Self Study Educational Resources Subcommittee EDITORIAL POSITIONS 1995 – Present Ad hoc reviewer, international Journal of Radiation Oncology- Biology-Physics 1997 – Present Ad hoc reviewer, Cancer 1999 – Present Ad hoc reviewer, Journal of Clinical Oncology 2005 - Present Editorial Board, Cancer Investigation 2006 – Present Editorial Board, Journal of Surgical Oncology EDUCATIONAL / TEACHING ACTIVITIES 1991 – Present Medical Student Education-Monthly Lecturer in Clinical Radiation Oncology for Rotating Medical Students 2-4 hours/month 1993 – 1994 Coordinator of Education Program For Residents in Radiation Oncology 1993 – 1995 Coordinator, Grand Rounds/Visiting Professor Lectureship schedule of The University of Maryland School of Medicine, Department of Radiation Oncology 5
    • 1995 – Present Weekly Multidisciplinary Thoracic Malignancy Conference 1 hr/week 1995 – Present Weekly Multidisciplinary Head and Neck Cancer Conference 1 hr/week EDUCATIONAL / TEACHING ACTIVITIES – Continued 1995 – Present Radiation Oncology Resident Research Preceptor 2 hrs/week 1995 – Present Radiation Oncology Resident Education Annual lectures in Clinical Radiation Oncology Morning quality assurance/teaching conference Monday Journal Club Mock Oral Board Examiner 8 hrs/week 1995 – Present Departmental Advisor/Research Mentor for Medical Students Entering the field of Radiation Oncology 1996 – Present Otolaryngology Resident Education Annual lectures in Clinical Radiation Oncology 3 hrs/year 1997 – Present Gastroenterology Fellow Education Annual lecture in Clinical Radiation Oncology 2 hrs/year 2001 – Present Medical Director of University of Maryland Dosimetry School (one of six certified programs in the country) 2-4 hrs/month 2004 - Present Question Writer for National In-Service exam for Radiation Oncology Residents in Training Exam (head and neck cancer section) 2007 Oral Board Examiner. American Board of Radiology (Head & Neck Cancer Section) MEDICAL STUDENT MENTORSHIP MEDICAL STUDENTS CLASS RESIDENCY PROGRAM Michael Garofalo 1999 University of Chicago Joseph Herman 2000 University of Michigan Zach Fowler 2000 Emory University Selma Jabbour 2001 Johns Hopkins Hospital Vladimir Ioffe 2001 Eastern Virginia Medical School Suneel Nada 2001 Rush Presbyterian Igor Poltinnkov 2001 Thomas Jefferson Medical College Josh Petit 2002 Massachusetts General Hospital Anil Dhople 2002 University of Maryland Medical System Todd Flannery 2003 University of Maryland Medical System 6
    • Steven Ronson 2004 Loma Linda University Pinaki Dutta 2004 University of Pennsylvania Suzannah Yavino 2005 University of Maryland Medical System Jerry Jaboin 2005 Vanderbilt University Total time dedicated to direct teaching activities – 20-25% effort. NATIONAL CLINICAL RESEARCH 1995 – Present Committee Member, Radiation Oncology Cancer and Leukemia Group B (CALGB) National Cooperative Study Group. Sponsored by The National Cancer Institute. 1996 – Present Principal Investigator University of Maryland School of Medicine (Full Member Institution), Radiation Oncology Therapy Group (RTOG) National Cooperative Study Group. Sponsored by the National Cancer Institute. (Funding: $75-100,000/year) Status: Ongoing 1998 – Present Principal Investigator (Radiation Oncologist) The Stents and Radiation Therapy Trial (START). Forty-center, National Registry Trial Evaluating the Use of Brachytherapy for In-Stent Coronary Artery Restenosis. Sponsored by the Novoste Corporation. Funding: $120,000 total cost Study: Study closed. 1998 – Present University of Maryland Physician Representative Elekta Oncology International Research Corsortium 1999 – Present Patterns of Care Study Esophageal Cancer Committee Member; Review Committee studying National Standards of Radiotherapy Practice for Esophageal Cancer. Sponsored by the American College of Radiology and the National Cancer Institute. Funding: $60,000 total cost Status: Study closed. 1999 – Present Principal Investigator (Radiation Oncologist) Stents and Radiation Therapy Trial (START 40) 50 Center National Collaborative Trial Evaluating the use of a 40 mm Source Train in the Management of In-Stent Coronary Artery Restenosis. Sponsored by the Novoste Corporation. 2001 – Present Thoracic Malignancies Steering Committee, Radiation Therapy Oncology Group Gastrointestinal Disease Site Steering Committee, Radiation Therapy Oncology Group. 2002 – Present Patterns of Care Study Representative to the American College of Surgeons for the Joint Evaluation of National Standards of Practice for Esophageal Cancer. Sponsored by the National Cancer Institute. 2003 – Present Principal Investigator RTOG L-0229 A Phase II Trial of Neoadjuvant Therapy with Concurrent Chemotherapy and High Dose Radiotherapy Followed by Surgical Resection, and Consolidative Therapy for Locally Advanced Non-Small Cell Lung Carcinoma. Multi-Institutional, Phase II Trial Status: Opened 10/04 7
    • 2003 – Present Vice Chairman, Radiation Therapy Oncology Group Member of the Executive Steering Committee of Radiation Therapy Oncology Group Chairman, Membership Committee, Radiation Therapy Oncology Group NCI Grant No. CA 21661 (5% effort with support). NATIONAL CLINICAL RESEARCH – Continued 2004 - Present Head and Neck Malignancies Steering Committee, Radiation Therapy Oncology Group. 2004 – Present Principal Investigator RTOG 0436 A Phase III Trial Evaluating the Addition of Cetuximab to Weekly Paclitaxel, Cisplatin, and Daily Radiation for Patients with Locally Advanced Esophageal Cancer. Multi-Institutional, Phase III Randomized Trial Status: Approved by NCI Intergroup Gastrointestinal Executive Steering Committee under CTEP Review INVESTIGATOR INITIATED CLINICAL RESEARCH PROTOCOLS 1996 Principal Investigator: The Role of Tirapazamine (SR4233) in Radiotherapy. New Investigator Award/Intramural Award; University of Maryland School of Medicine. Funding: $15,000 1998 Institutional Principal Investigator: Novoste sponsored BetaCath Trial of Intravascular Radiation to Prevent Coronary Artery Restenosis. Funding: $80,000 total cost Status: Study closed, accrual complete 1998 Institutional Principal Investigator: Stent or Radiation Therapy Intervention for Esophageal Cancer Dysphagia (SORTIE) Plan, Multi-Center Trial Comparing Stents Versus External Beam Radiation for Palliation in Esophageal Cancer Patients. Sponsored by Boston Scientific. Funding: $20,000 total cost Status: Study closed, accrual complete 1999 (IRB #0799205) Principal Investigator: Phase I/II Feasibility Study of Intensity Modulated Radiation Therapy for Newly Diagnosed Cancer Patients. Sponsored by Elekta Corporation. Funding: $20,000 Status: Study closed, accrual complete 1999 Principal Investigator: A Phase I Study of UFT and Hydroxyurea Plus Hyperfractionated Re- irradiation Therapy for Patients with Recurrent Squamous Cell Carcinoma of the Head and Neck. Sponsored by Bristol-Myers Squibb. Funding: $60,000 Status: Study Closed, accrual complete 1999 (GCC #98-39) Principal Investigator: A Phase I Study of Paclitaxel, UFT, Leucovorin and Radiation Therapy for Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck. Sponsored by Roche Pharmaceuticals. Funding: $60,000 Status: Study closed, accrual complete 2000 (GCC #99-67) Principal Investigator: Cisplatin, 5-FU and Accelerated Hyperfractionation with a 8
    • Concomitant Boost Followed by Surgical Resection then Docetaxel Chemotherapy for Patients Presenting with Locally Advanced Esophageal Carcinoma. Sponsored by Adventis Pharmaceuticals. Funding: $250,000 Status: Study closed, accrual complete INVESTIGATOR INITIATED CLINICAL RESEARCH PROTOCOLS - Continued 2000 (GCC #00-67) Institutional Principal Investigator: A Multinational, Multicenter, Double-Blind, Placebo Controlled, Randomized, Phase III, Clinical Trial to Determine the Efficacy and Safety of IB-367 Rinse in Reducing the Severity of Oral Mucositis in Patients Receiving Radiotherapy for Head and Neck Malignancies. Sponsored by Intrabiotics Corporation. Funding: $20,000 Status: Closed. 2000 Principal Investigator: The Predictive Value of Thymidylate Synthase, Thymidine Phosphorylase, and Dihydropyrimidine Dehydrogenase in Chemoradiation Strategies for Squamous Cell Carcinoma of the Head and Neck. Sponsored by Roche Pharmaceuticals. Funding: $142,000 2001 (GCC #00-14) Principal Investigator: A Phase I Study of Docetaxel, Carboplatin, and Accelerated Fractionation with Concomitant Boost Radiation Therapy for Patients with Advanced Loco-Regional Squamous Cell Carcinomas of the Head and Neck. Sponsored by Adventis Pharmaceuticals. Funding: $64,500 direct costs Status: Study closed to accrual. 2002 Principal Investigator: A Single Site Evaluation of Amifostine for Mucosal and Hermopoetic Protection, and Concurrent Carboplatin, Paclitaxel and Radiotherapy in the Management of Patients with Advanced Loco-Regional Squamous Cell Carcinomas of the Head and Neck. Sponsored by Medimmune, Inc. Funding: $68,700 direct costs Status: Study closed, accrual complete. 2003 Principal Investigator: Non-Operative Therapy of Local Regional Carcinoma of the Esophagus. A Phase II Study of Paclitaxel, Carboplatin and Radiotherapy. Sponsored by Bristol-Myers Squibb Oncology. Funding: $123,750 total costs Status: Study closed 2004 Co-Principal Investigator: Cetuximab, Paclitaxel, Carboplatin and Radiation for Esophageal Gastroesophageal Junction and Gastric Cancer Multicenter Trial Including, Brown University, and University of Maryland. Sponsored by Bristol-Myers Squibb Oncology. Funding: $250,000 total costs Status: Study open; accruing patients. 2004 Principal Investigator: A Phase II Study of Evaluation of Cetuximab (ERBITUX) and Concurrent Carboplatin, Paclitaxel and Radiotherapy in the Management of Patients with Advanced Locoregional Squamous Cell Carcinomas of the Head and Neck. Sponsored by Bristol-Myers Squibb Oncology. Funding: $302,709 total costs Status: Study open, accruing patients. PUBLICATIONS – JOURNAL ARTICLES 1. Galkin, B., Feig, S., Mieur H., Suntharalingam, M. Photomicrographics of Breast Calcification Correlation with Histopathological Diagnosis. Radiographics, 3:3, 450-477, 1985. 9
    • 2. Espinoza-Jacobs, M., Suntharalingam, M., et al. Combined Carbo Platinum CBDCA-Bleomycin (BLEO) and Conventional Radiotherapy for Advanced Unresectable Squamous Cell Carcinoma of the Head and Neck, American Journal of Clinical Oncology, 18:1, 52-55, 1995. PUBLICATIONS – JOURNAL ARTICLES – Continued 3. Suntharalingam, M., Rudoltz, M.S., Mendenhall, W.H., Parsons, J.T., Stringer, S.P., Million, R.R. The Role of Radiotherapy in the Management of Merkel Cell Carcinoma of the Skin on the Head and Neck. Head and Neck, 17, 96-101, 1995. 4. Rhee, J.G., Eddy, H.A., Hong, J.J., Suntharalingam, M., Vaupel, P.W. Divergent Changes of Diameter and Flow Through Individual Blood Vessels Upon Localized Heating. Int. J. Hyperthermia, 12:6, 757-769, 1996. 5. Um, K., Cheston, S., Suntharalingam, M., Rhee, J. Reduced Adriamycin Cytotoxicity in RIF-1 Multi- Cell Spheroid Due to an Acidic Microenvironment. Environmental Mutagens and Carcinogins. 17:1, 7-11, 1997. 6. Conley, B., Jacobs, M., Suntharalingam, M., Zacharski, D., Ord, R., Gray, W., Aisner, J. The Role of Paclitaxel/Carboplatin and Concurrent Radiotherapy in Unresectable Squamous Cell Carcinoma of the Head and Neck. Seminars in Radiation Oncology. 7:2, Supp (1), 139-141, 1997. 7. Conley, B., Jacobs, M., Suntharalingam, M., Zacharski, D., Ord, R., Gray, W., Aisner, J. A Pilot Trial of Paclitaxel, Carboplatin and Concurrent Radiotherapy for Unresectable Squamous Cell Carcinoma of the Head and Neck. Seminars in Oncology, 24:1, Supp. (2), 787-780, 1997. 8. Sonett, J., Krasna, M., Suntharalingam, M., Doyle, A., Scheutz, J., McLaughlin, J. Interior Trap-Door Surgical Approach for Advanced Stage Lung Cancer Following Neoadjuvant Chemotherapy and Radiotherapy. Penn Assoc Thor Surg, 6, 51-55, 1998. 9. Rhee, J., Liu, J., Suntharalingam, M. Halo Comet Assay Triage of Irradiated Personnel. Armed Forces Radiobiology Research Institute, D5-9, 1998. 10. Sonett, J.R., Krasna, M.J., Suntharalingam, M., Scheutz, J., Gamliel, Z., McLaughlin, J. Safe Pulmonary Resection After Chemotherapy and High Dose Thoracic Radiation. Annals of Thoracic Surgery, 68, 316-320, 1999. 11. Krasna, M.J., Mao, Y.S., Sonett, J.R., Tamura, G., Jones, R., Suntharalingam, M., Meltzer, S.F. P53 Gene Protein Expression Predicts Response and Survival in Esophageal Cancer Patients Treated by Tri-Modality Therapy. Annals of Thoracic Surgery, 68, 2021-2025, 1999. 12. Park, S.H., Gray, W.C., Hernandez, I., Jacobs, M.C., Ord, R.A., Suntharalingam, M., Van Echo, D.A., Wu, S., Conley, B.A., A Phase I Trial of All-Trans Retinoic Acid (ATRA) in Patients with Treated Head and Neck Squamous Carcinoma. Clin Cancer Res, 6:3, 847-854, 2000. 13. Li, X.A., Wang, R, Yu C, Suntharalingam, M. Beta versus Gamma for Catheter-Based Intravascular Brachytherapy: Dosimetric Perspectives in the Presence of Metallic Stents and Calcified Plaques. Int. J. Radiation Oncology, Biol. Phys. 46,4: 1043-1049, 2000. 14. Suntharalingam, M, Haas, M, Conley, BA, Egorin, MJ, Levy, SG, Herman JM, Jacobs, MC, Gray, 10
    • WC, Ord, RA, Aisner, J, Van Echo, DA. Radiation Therapy with Concurrent Weekly, Carboplatin and Paclitaxel in Advanced Stage Unresectable Squamous Cell Carcinomas of the Head and Neck. Int. J. Radiat Oncol Biol Phys, 47(1):49-56, 2000. 15. Suntharalingam, M, Sonett JR, Haas ML, Doyl LA, Hausner, PF, Scheutz J, Krasna MJ. The Use of Concurrent Chemotherapy with High Dose Radiation Prior to Surgical Resection in Patients Presenting with Apical Sulcus Tumors. The Cancer Journal of the Scientific American, 6,6:365-371. 2000. PUBLICATIONS – JOURNAL ARTICLES – Continued 16. Suntharalingam, M. Radiation Therapy for Esophageal Cancer. Chest Surgery Clinics of North America, 10:3, 569-581, 2000. 17. Suntharalingam, M. , Haas, M.L., Van Echo, D.A., Haddad, R., Jacobs, M.C., Levy, S., Gray, W.C.., Ord, R.A., Conley, B.A. Predictors of Response and Survival Following Concurrent Chemotherapy and Radiation for Locally Advanced Squamous Cell Carcinomas of the Head and Neck Cancer, 91, 448-554, 2001. 18. Lee, Y.C., Chen, J.C., Amoscato, A.A., Bennouna, J., Spitz, D.R., Suntharalingam, M., Rhee, J.G. Protective Role of BCL-2 in Metabolic Oxidative Stress-Induced Cell Death. J of Cell Science, 114:4, 677-684, 2001. 19. Li, X.A., Suntharalingam, M. Dosimetry of Source Stepping for Intravascular Brachytherapy. Cardiovasc Radiat Med, 2:3, 165-172, 2001. 20. Suntharalingam, M., Haas, M., Sonett, J., Doyle, L.A., Hausner, P.F., Scheutz, J., Greenwald,B., Krasna, M.J. Accurate Lymph Node Assessment Prior to Trimodality Therapy for Esophageal Carcinoma. The Cancer Journal of the Scientific American, 7(6), 509-511, 2001. 21. Suntharalingam, M. Innovations in the Radiotherapy of Head and Neck Cancer, Veterans Health System Journal, 6:3, 54-58, 2001. 22. Jiao, X., Krasna, M.J., Sonett, J., Gamliel, Z., Suntharalingam, M., Doyle, A., Greenwald, B. Pre- Treatment Surgical Lymph Node Staging Predicts Results of Trimodality Therapy in Esophageal Cancer. European J of Cardio-Thoracic Surgery, 19, 880-886, 2001. 23. Ma, L., Yu, C.X., Earl, M., Holmes, T., Safaraz, M., Li, X.A., Shepard, D., Amin, P.A., DiBiase, S., Suntharalingam, M., Mansfield, C.M. Optimized Intensity Modulated Arc Therapy for Prostate Cancer. Int J Cancer, 96, 379-384, 2001. 24. Li, B., Yu, J., Suntharalingam, M., Kennedy, A.S., Amin, P.A, Chen, Z., Yin, R., Guo, S., Han T., Wang, Y, Yu, N., Song, G., Wong, L. Comparison of Three Treatment Options for Single Brain Metastasis from Lung Cancer. Int J Cancer, 90:1, 37-45, 2002. 25. Jiao, X., Sonett, J., Gamliel, Z., Doyle, A., Scheutz, J., Greenwald, B., Suntharalingam, M., Krasna, M.J. Trimodality Treatment versus Surgery Alone for Esophageal Cancer. A Stratified Analysis with Minimally Invasive Pretreatment Staging. Journal of Cardiovascular Surgery, 43(4) 531-7, August 2002. 26. Song, J.J. Rhee, J.G., Suntharalingam, M., Walsh, S.A., Spitz, D.R., Lee, Y.J. Role of Glutaredoxin in Notabolic Oxidative Stress. Glutaredoxin as a Sensor of Oxidative Stress Medicated by H202. 11
    • Journal of Biochemistry, 277 (48); 465-75, November 2002. 27. Yu, X.A., Li, A.X., Ma, L., Chen, D., Naqvi, S., Shepard, D., Safaraz, M., Holmes, T., Suntharalingam, M., Mansfield, C.M. Clinical Implementation of Intensity Modulated Arc Therapy. International Journal of Radiation Oncology, Biology and Physics, 53:2, 453-463, 2002. 28. Suntharalingam, M., Laskey, W., Lansky, A.J., Waksman, R., White, L., Teirstien, P., Massulio, Va., Rutherford, B., Elman, A., Kuntz, R.E., Popma, J.J., Bonan, R. START 40 Investigators. Clinical and Angiographic Outcomes After Use of 90Strontium/90Yttrium Beta Radiation for the Treatment of In- Stent Restenosis: Results from the Stents and Radiation Therapy 40(START 40) Registry. International Journal of Radiation Oncology, Biology and Physics, 52:4, 1075-1082, 2002. PUBLICATIONS – JOURNAL ARTICLES – Continued 29. Popma, J.J., Suntharalingam, M., Lansky, A.J., Heuser, R.R., Speiser, B., Teirstrein, P.S., Massullo, V., Bass, T., Henderson, R., Silber, S., von Rottkay, P., Bonan, R., Ho, K.H.K, Kuntz, R. A Randomized Trial of 90Strontium/90Yttrium Beta Radiation Versus Placebo Control for the Treatment of In-Stent Restenosis. Circulation, 106:9, 1090-1096, 2002. 30. Morino, Y., Kaneda, H., Fox, T., Takagi, A., Hassan, H.M., Honda, Y., Bonan, R., Crocker, I., Lansky, A.J., Laskey, W.K., Suntharalingam, M., Bonneau, H.N., Yock, P.G., Fitzgerald, P.J. Delivered Dose and Vascular Response Following Beta Radiation for In-Stent Restenosis: Retrospective Dosimetry and Volumetric Intravascular Ultrasound Analysis. Circulation, 106:18, 2334-2339, 2002. 31. Li, X.A., Chilbani, O., Greenwald, B., Suntharalingam, M. Radiotherapy Dose Pertubation of Metallic Esophageal Stents. International Journal of Radiation Oncology, Biology and Physics, 54:4, 1276-1285, 2002. 32. Mao, Y.S., Suntharalingam, M., Krasna, M.J. Management of Late Distant Metastases After Trimodality Therapy for Esophageal Cancer. The Annals of Thoracic Surgery, 76:5, 1742-1743, March 2003. 33. Suntharalingam, M., Laskey, W.K., Tan, J., Kuntz, R., Bonan, R. Vascular Brachytherapy Using A Beta Emitter in Diabetic Patients with In-Stent Restenosis: Angiographic and Clinical Outcomes. International Journal of Radiation Oncology, Biology and Physics, 57:2, 536-542, October 2003. 34. Suntharalingam, M., Moughan, J., Cola, L.R., Krasna, M.J., Kachnic, L., Haller, D.G., Willet, C.G., John, M.J., Minksy, B.D., Owens, J.B. The National Practice for Patients Receiving Radiation Therapy for Carcinoma of the Esophagus: Results of the 1996-1999 Patterns of Care Study. International Journal of Radiation Oncology, Biology and Physics, 56:4, 981-987, 2003. 35. Timmerman, R., Papiez, L., Suntharalingam, M. Extracranial Stereotactic Radiation Delivery: Expansion of Technology Beyond the Brain. Technology in Cancer Research and Treatment, 2:2, 153-160, 2003. 36. Edelman, J.J., Suntharalingam, M., Krasna, J.J. The Management of the Patient Undergoing Combined Modality Therapy for Locally Advanced Non-Small Cell Lung Cancer. Current Treatment Options in Oncology, 4, 45-53, 2003. 37. Flannery, T.A., Suntharalingam, M., Kwok, Y., Koffman, B.H., Amin, P.a., Chin, L.S., Nichol, B., Fowler, B., Young, B., Regine, W.F. Gamma Knife Stereotactic Radiosurgery for Synchronous Versus Metachronous Solitary Brain Metastases from Non-Small Cell Lung Cancer. Lung Cancer, 32:3, 327-333, December 2003. 12
    • 38. Rhee, J.G., Li, D., Guo, M., O’Malley Jr, B.W, Suntharalingam, M. Combination Radiation and Adenovirus Mediated p16 (INK4A) in a Murine Model for Head and Neck Cancer. Journal of ORL, 65:3, 144-154, June 2003. 39. O’Malley Jr, B.W., Li, D., Carney, J., Rhee, J., Suntharalingam, M. Molecular Disruption of the MRN(95) Complex Induces Radiation Sensitivity in Head and Neck Cancer. Laryngoscope, 13:9, 1588-1594, September 2003. 40. Brady, D., Yu, S.Z., Koprowski, H., Rhee, J., Kuman, S., Pericle, F., Suntharalingam, M., Van Echo, D.A., Li, D., O’Malley Jr., B.W. Combination Non-Viral Interleukin-2 Gene Therapy and External Beam Radiation Therapy for Head and Neck Cancer. Archives of Otolaryngol Head and Neck, 129:6, 618-622, June 2003. PUBLICATIONS – JOURNAL ARTICLES – Continued 41. Suntharalingam, M. The Role of Concurrent Chemotherapy and Radiation in the Management of Patients with Squamous Cell Carncinomas of the Head and Neck. Seminars in Oncology, 30:4, Suppl (9), 37-45, August 2003. 42. Suntharalingam, M., Jaboin, J, Taylor, R., Wolf, J., Bangalore, M., Van Echo, D., Ord, R. The Evaluation of Amifostine for Mucosal Protection in Patients with Advanced Lco-Regional Squamous Cell Carcinomas of the Head and Neck (SCCHN) Treated with Concurrent Weekly Carboplatin, Paclitaxel and Daily Radiotherapy (RT). Seminars in Oncology, 31 (6 Suppl 18), 2-7, December 2004 43. Sonett, J.R., Suntharalingam, M., Edelman, M.J., Gamliel, Z., Doyle, A., Hausner, P., Dickerson, A., Krasna, M.J. Pulmonary Resection Following Neoadjuvant High Dose Curative Intent Radiotherapy (>59Gy) and Concurrent Chemotherapy. The Annals of Thoracic Surgery, 78:4, 1200-1205, October 2004. 44. Patel, A.B., Edelman, M.J., Kwok, Y., Krasna, M.J., Suntharalingam, M. Predictors of Acute Esophagitis in Patients with Non-Small Cell Lung Carcinoma Treated with Concurrent Chemotherapy and Hyperfractionated Radiation Therapy Followed by Surgery. The International Journal of Radiation Oncology, Biology and Physics, (60) 4:1106-1112, 2004. 45. Rhee, J.G., Li, D., Suntharalingam, M., O’Malley, B.W., Guo, G., Carney, J.P. Radiosensitization of Head/Neck Squamous Cell Carcinoma by Adenovirus-Mediated Expression of the Nbs1 Protein. Accepted with revisions, International Journal Radiation Oncology Biology Physics, February, 2005. 46. Silber, S., Popma, J.J., Suntharalingam, M., Lansky, A.J., Heuser, R.R., Spieser, B., Teirstein, P.S., Bass, T., O’Neill, W., Lasala, J., Reisman, M., Sharma, S.K., Kuntz, R.E., Bonan, R. Two-Year Clinical Follow-Up of 90 Sr/90 Y Beta Radiation Versus Placebo Control for the Treatment of In-Stent Restenosis. The American Heart Journal, 149: 689-694, 2005. 47. Yovino, S., Kwok, Y., Krasna, MJ., Bangalore, M., Suntharalingam, M., An association between preoperative anemia and decreased survival in early-stage non-small-cell lung cancer patients treated with surgery alone. Int J Radiat Oncol Biol Phys, 62(5), 1438-43, August 2005. 48. Kwong, K., Cooper, L., Edelman, M.J., Gamliel, Z., Suntharalingam, M., Burrows, W., Hausner, P., Doyle, L.A., Krasna, M.J. High-Dose Radiation in tri-Modality Treatment of Pancoast tumors Results in High Pathologic Complete Response Rates and Excellent Long-term Survival. The Journal of Thoracic and Cardiovascular Surgery, 29 (6) 1250-7, June 2005. 13
    • 49. Suntharalingam, M., Moughan, J., Coia, L.R., Krasna, M.J., Kachnic, L., Haller, D.G., Willett, C.G., John, M.J., Minsky, B.D., Owen, J. Outcome Results of the 1996-1999 Patterns of Care Survey of the National Practice for Patients Receiving Radiation Therapy for Carcinoma of the Esophagus. Journal of Clinical Oncology, 20, 10:2325-2331, 2005. 50. Li, XA, O’Neill, M., Suntharalingam, M. Improving patient-specific dosimetry for intravascular brachytherapy. Brachytherapy, 4: 291-97, 2005. 51. Rhee, J.G., Li, D., Suntharalingam, M., O’Malley, B.W., Guo, G., Carney, J.P. Radiosensitization of Head/Neck Squamous Cell Carcinoma by Adenovirus-Mediated Expression of the Nbs1 Protein. Accepted with revisions, International Journal Radiation Oncology Biology Physics, February, 2005. 52. Bangalore, M., Matthews, S., Suntharalingam, M. Recent Advances in Radiation Therapy for Head and Neck Cancer. Journal for Otorhinolaryngology, November 2006. 53. Balcer-Kubiczek, E., Attarpour, M., Jiang, J., Kennedy, AS, Suntharalingam, M. Cytotoxicity of Docetaxel (Taxotere) used as a Single Agent and in Combination with Radiation in Human Gastric, Cervical and Pancreatic Cancer Cells. Chemotherapy, 52:231-240, 2006. 54. Suntharalingam, M. Definitive chemoradiation in the management of locally advanced esophageal cancer. Seminars in Oncology, 17(1), 22-28, January 2007. 55. Safran, H., Suntharalingam, M., Dipetrillo, T., Ng, T., Doyle, LA, Krasna, MJ, Plette, A., Evans, D., Wanebo, H., Akerman, P., Spector, J., Kennedy, N., Kennedy, T. Cetuximab with Concurrent Chemoradiation for Esophagogastric Cancer: Assessment of Toxicity. Int J Radiat Oncol Phys., November 2007. 56. Rhee, JG, LI, D., Suntharalingam, M., Guo, C., O’Malley, BW, Carney, JP. Radiosensitization of head/neck squamous cell carcinoma by adenovirus-mediated expression of the Nbs 1 protein. Int J Radiation Oncol Biol Phys, 67(1), 273-78, January 2007. 57. Machtay, M., Pajak, TF, Suntharalingam, M., Shenouda, G., Hershock, D., Stripp, DC, Cmelak, AJ., Schulsinger, A., Fu, KK. Radiotherapy with or without Erythropoietin for Anemic Patients with Head and Neck Cancer: A Randomized Trial of the Radiation therapy Oncology Group (RTOG 99-03). Int J Radiat Oncol Biol Phys, 69(4) 1008-1017, October 2007. 58. D’Souza, WD, Nazareth, DP, Zhang, B., DeYoung, C., Suntharalingam, M. Kwok, Y., Yu, CX, Regine, WF. The Use of Gated and 4D CT Imaging in Planning for Stereotactic Body Radiation Therapy. Med Dosim, 32(2), 92-101, May 2007. BOOK CHAPTERS 1. Salazar, O.M., Suntharalingam, M. Palliative Radiation for Widespread Pulmonary Disease in Medical Radiology in Kagan R., Steckel, R., (eds), Practical Approaches to Cancer Invasion and Metastasis. Springer Verlag, 1994. 2. Suntharalingam, M. Principles and Complications of Radiation Therapy in Ord, R.A and Blanchart, R.H. (eds), Oral Cancer: The Dentist’s Role in Diagnosis, Management, Rehabilitation and Prevention. Quintessence Publishing, 1999. 14
    • 3. Paz, I.B., Suntharalingam, M., Leichman, L. Esophageal Cancer in Pazdur, R., Coia, L.R., Hoskins, W.J., Wagman, L.D. (eds), Cancer Management: A Multidisciplinary Approach. Medical, Surgical and Radiation Oncology, 5th Edition, PRR Inc, 2001. 4. Paz, I.B., Suntharalingam, M., Hwang, J.J., Marshall, J.L., Leichman, L. Esophageal Cancer in Pazdur, R., Coia, L.R., Hoskins, W.J., Wagman, L.D. (eds), Cancer Management: A Multidisciplinary Approach. Medical, Surgical and Radiation Oncology, 5th Edition, PRR Inc., 2002. 5. Moore-Higgins, G.J., Strohl, R.A., Suntharalingam, M. Lung Cancer, in Bruner, D.W., Moore- Higgins, G.J., Haas, M. (eds), Outcomes in Radiation Therapy. Multidisciplinary Management, 2001. 6. Paz, I.B., Suntharalingam, M., Hwang, J.J., Marshall, J.L., Leichman, L. Esophageal Cancer in Pazdur, R., Coia, L.R., Hoskins, W.J., Wagman, L.D. (eds), Cancer Management: A Multidisciplinary Approach. Medical, Surgical and Radiation Oncology, 8th Edition, PRR Inc., 2003. 7. Paz, I.B., Hwang, J.J., Marshall, J.L., Leichman, L., Suntharalingam, M. Esophageal Cancer in Pazdur, R., Coia, L.R., Hoskins, W.J., Wagman, L.D. (eds), Cancer Management: A Multidisciplinary Approach. Medical, Surgical and Radiation Oncology, 8th Edition, PRR Inc, 2004. 8. Suntharalingam, M, Settle, K., Cullen, K. Perspective on Fractionated Radiation and Chemotherapy for Head and Neck Tumors, Chin, L., Regine, W.F. (eds) in Principles and Practice of Stereotactic Radiosurgery, 1st edition, Springer, 2005. POSTER PRESENTATION 1. Suntharalingam, M., Rhee, J., Eddy, H., Salazar, O.M. Reoxygenation Kinetics in RIF-1 Multi-Cell Spheroids Characterized by the Changes in Cytotoxicity of X-Rays and SR-4233, A Hypoxic Cell Toxin. Presented at the American Society for Therapeutic Radiology and Oncology Annual Meeting. San Francisco, CA, October, 1994. 2. Suntharalingam, M., Ampey, L.L. A Radiobiologic Evaluation of Overall Treatment Time in Patients with Early Stage Glottic Carcinoma. Presented at The American Radium Society Annual Meeting. Paris, France, April 29 – May 3, 1995. 3. Moon, S.D.M., Suntharalingam, M., Liu, J, Rhee, J.G. Reoxygenation Patterns of RIF-1 Multi-Cell Spheroids Determined by Halo and Halo-Comet Assays Following SR-4233 Exposures. Presented at the Radiation Research Society Meeting. Chicago, IL, April, 1996. 4. Rhee, J.G., Lee, K.H., Liu, J., Um, K.I., Vines, E., Suntharalingam, M. A Constant Level of HSP70 During a Transitional Period from a Heat-Sensitive to a Heat-Resistant State Following Dispersion of RIF-1 Spheroids. Presented at the North American Hyperthermia Society Meeting. Providence, RI, May, 1997. POSTER PRESENTATION – Continued 5. Park, S., Suntharalingam, M., Gray, W., Saraf, W., Elias, G. Comparison of Condensed Modality Treatment with Chemotherapy and Radiation Versus Radiation Alone on Patients with Nasopharyngeal Cancer: A Retrospective Review. Presented at the 1997 Annual Meeting of the Society of Head and Neck Surgeons. Cancun, Mexico, April 10-12, 1997. 15
    • 6. Rhee, J.G., Suntharalingam, M., Mansfield, C.M. Localization of Tirapazamine Induced DNA Damage in RIF-1 Multi-Cell Spheroids; in Situ Alkaline Comet Assay (ISACA). Presented at the Radiation Research Society Meeting. Louisville, KY, May 1998. 7. Wong, A., Suntharalingam, M., Doyle, A., Sonett, J., Krasna, M., Greenwald, B.D. Endoscopic Assessment of Tumor Viability After Combined Chemoradiation for Esophageal Cancer. Presented at the Annual Meeting of the American Society of Gastrointestinal Endoscopists, Digestive Disorders Week. New Orleans, LA, May 1998. 8. Suntharalingam, M., Conley, B.A., Van Echo, D.A., Jacobs, M.C., Levy, S.G., Li, B., Ord, R.A., Gray, W.C., Aisner, J.A. Evaluation of Response and Survival in Unresectable SCCHN Treated with Chemoradiation on Three Consecutive Institutional Trials. Presented at the First International Chicago Symposium on Malignancies of the Chest, Head and Neck. October 1-2, 1999. 9. Haddad, R.I., Suntharalingam, M., Chen,T., Levy, S., Van Echo, D.E. Pre-Treatment Hemoglobin is Associated with Response to Chemoradiation (CRT) in Patients with Advanced Unresectable Squamous Cell Carcinoma of the Head and Neck. Presented at the American Society of Clinical Oncology Annual Meeting. New Orleans, LA, May 20-23, 2000. 10. Fowler, B.Z., Suntharalingam, M., Koffman, B.H., Nichols, B., Chin, L., Amin, P.A., Young, A.B., Regine, W.F. Gamma Knife Stereotactic Radiosurgery for Synchronous Versus Metachronous Solitary Brain Metastases from Non-Small Cell Lung Cancer. Presented at The American Society of Therapeutic Radiology and Oncology 42nd Annual Meeting. Boston, MA, October 22-26, 2000. 11. Ma, L., Yu, C., Safaraz, M., Holmes, T., Sheppard, D., Li, A., Dibiase, S., Amin, P., Suntharalingam, M., Mansfield, C. Simplified Intensity Modulated Arc Therapy for Prostate Cancer Treatments. Presented at the American Society of Therapeutic Radiology and Oncology 42nd Annual Meeting. Boston, MA, October 22-26, 2000. 12. Suntharalingam, M., DeYoung, C.M., Edelman, M.J., Greenwald, B., Duckham, E., Krasna, M.J. Concomitant Boost RT as Part of an Induction Regimen Followed by Surgery and Adjuvant Docetaxel for Locally Advanced Esophageal Cancer. Presented at the 38th Annual Meeting of the American Society of Clinical Oncology. Orlando, FL, May 18-21, 2002. 13. Sullivan, PH, Taylor, R, Ord R, Wolf, J, VanEcho D, Kwok Y, Suntharalingam, M. Long-Term Survival and Functional Quality of Life Assessments in Patients with Locally Advanced Unresectable Squamous Cell Carcinomas of the Head and Neck Treated with Concurrent Chemoration, presented at the 45th Annual Meeting of the American Society of Therapeutic Radiology and Oncology, Atlanta, GA, Oct. 3-7, 2004. 14. Yovino S, Kwok Y, Krasna MJ, Bangalore M, Suntharalingam, M. Preoperative Anemia Decreases Survival in Patients with Stage I and II Non-Small Cell Lung Cancer. Presented at the 46th Annual Meeting of the American Society of Therapeutic Radiology and Oncology, Atlanta, GA, October,2004. 15. Suntharalingam, M., Wolf, J., Taylor, R., Jaboin, J., Bangalore, M., Ord, R., Cullen, K. The Evaluation of Amifostine for Mucosal Protection in Advanced Loco-Regional Squamous Cell Carcinomas of the Head and Neck (SCCHN) Treatment with Concurrent Weekly Carboplatin, Paclitaxel, and Daily Radiotherapy (RT). Presented at the American Society of Therapeutic Radiology and Oncology (ASTRO) 47th Annual Meeting. Denver, CO, October 16-20, 2005. NATIONAL PRESENTATIONS – INVITED SPEAKER 16
    • 1. Radiation Modifiers: From Discovery to Reality: Suntharalingam, M., Salazar, O.M. Presented at the 8th Biennial Meeting of Circulo De Radioterapeutas Ibero Latino Americans (CRILA). San Juan, Puerto Rico, May 4-8, 1992. 2. Technical Considerations of Ultrasound and Template Guided I125 Implantation for Early Stage Prostate Cancer. Presented at the Mid-Atlantic Society for Radiation Oncology Meeting. Richmond, VA, September 23, 1992. 3. Organ Preservation in Advanced Larynx Cancer: A Radiation Oncologist’s Perspective. Presented at the Southern Medical Association Annual Meeting. Baltimore, MD, November 22, 1996. 4. Management of Bulky Lymph Nodes as Part of Combined Modality Therapy for Advanced Head and Neck Cancers. Presented at the Southern Medical Association Annual Meeting. Baltimore, MD, November 22, 1996. 5. Treatment Role of Radiation Therapy in the Management of Patients with Localized Advanced NSCLS. Presented at the Recent Advances in the Treatment of Ovarian Cancer and Lung Cancer Conference. Baltimore, MD, June 13, 1997. 6. Staging and Combined Modality Treatment for Esophgeal Cancer Radiation Oncology with Tri- Modality Treatment Panel Discussion. Presented at the Multidisciplinary Treatment of Solid Tumors Conference, Baltimore, MD, September 19-20, 1997. 7. Multidisciplinary Treatment of Solid Tumors Conference. Baltimore, MD, September 19-20, 1997. 8. The University of Maryland Experience with the Beta Cath Trial. Presented at the Novosote European Investigators Meeting. Brussels, Belgium, June 1998. 9. The Use of Radiation Therapy to Prevent Coronary Artery Restenosis. Presented at the Radiation Oncology Ground Rounds, Rush Presbyterian Hospital. Chicago, IL, July 1998. 10. Radiation Therapy with Concurrent Weekly Carboplatin and Paclitaxel in Advanced Stage Unresectable Squamous Cell Carcinomas of the Head and Neck. Presented at the Fox Chase Cancer Center Investigator Workshop. Lanai, HI, March 11-15, 2000. 11. Clinical Implementation of Intensity-Modulated Arc Therapy. Presented at the International Symposium on Intensity-Modulated Radiation Therapy. Jefferson Medical College, Philadelphia, PA, March 17-18, 2000. 12. The Role of Radiation in the Prevention of Vascular Restenosis. Presented at the Device Workshop at the Society of Cardiac Angiography and Interventions Meeting. Charleston, SC, May 4, 2000. 13. The Role of Vascular Brachytherapy in the Prevention of Coronary Artery Restenosis. Presented at the American College of Medical Physicist (ACMP) Annual Meeting. Vancouver, Canada, May 18, 2000. 14. Combining Radiation and Chemotherapy in the Treatment of Head and Neck Carcinomas. Presented at Oncology Ground Rounds, University of Louisville. Louisville, KY, August 17, 2000. 15. The Role of Radiation in the Prevention of Coronary Artery Restenosis. Presented to the Department of Radiation Oncology and Combining Radiation and Chemotherapy in the Treatment of Head and Neck Carcinomas. Presented at Oncology Ground Rounds as Visiting Professor, Department of Radiation Medicine, University of Kentucky. Lexington, KY, August 18, 2000. NATIONAL PRESENTATIONS – INVITED SPEAKER – Continued 17
    • 16. Advances in the Treatment of Head and Neck Cancer. Presented at Cancer Center Ground Rounds, Divine Providence Hospital. Williamsport, PA, August 29, 2000. 17. Innovations in the Use of Radiotherapy for Head and Neck Cancer. Presented at the 5th Annual National VA Oncology Symposium. Alexandria, VA, October 5, 2000. 18. Multi-Modality Treatment for Early Stage Head and Neck Carcinomas. Presented at the Bristol-Myers Squibb Oncology Physician Speakers Training Program. Chicago, IL, October 5-7, 2000. 19. Implementation of a Vascular Brachytherapy Program. Presented at the Transcatheter Therapeutics National Meeting. Washington, DC, October 19, 2000. 20. IMRT Delivery Approaches and Clinical Experience with IMAT (Intensity Modulated Radiation Therapy). Presented at the Elekta Symposium on Advanced Clinical Solutions in Conformal Radiotherapy (IMRT) and Gamma Knife Surgery, American Society of Therapeutic Radiology and Oncology 42nd Annual Meeting. Boston, MA, October 21, 2000. 21. Moderator - Scientific Session on Coronary Vascular Radiation at the 42nd Annual Meeting of the American Society for Therapeutic Radiology and Oncology. Boston, MA, October, 30, 2000. 22. Clinical Applications of Intensity-Modulated Radiation Therapy. Presented at the Gulf Coast Oncology Center. Panama City, FL, November 13, 2001. 23. Combined Modality Management of Head and Neck Cancer. Presented at Educational Symposium at the American Society of Therapeutic Radiation and Oncology Annual Meeting. San Francisco, CA, November 4, 2001. 24. Moderator - Endovascular Brachytherapy Scientific Session at the 43rd Annual Meeting of the Association for Therapeutic Radiology and Oncology. San Francisco, CA, November 7, 2001. 25. The Role of Endovascular Brachytherapy in the Management of In-Stent Restenosis. Presented at the 2001 Scientific Symposium of the Delaware Valley Chapter of the American Association of Physicists in Medicine Meeting, Jefferson Medical College. Philadelphia, PA, December 7, 2001. 26. Co-Moderator of the Annual Simon Kramer Institute Symposium for the Development of a New Staging System for Esophageal Cancer. New Philadelphia, PA, August 25, 2001. 27. The Role of Staging in the Treatment of Esophageal Cancer with Pre-Operative Chemotherapy and Radiation. Presented at the Annual Simon Kramer Institute Symposium for the Development of a New Staging System for Esophageal Cancer. New Philadelphia, PA, August 25, 2001. 28. The University of Maryland Experience with Chemoradiation in Locally Advanced Head and Neck Cancer. Presented at the Fox Chase Cancer Center Investigator Workshop. Kohala, HI, March 23-27, 2002. 29. Current Trends in the Management of Locally Advanced Carcinomas of the Head and Neck. Presented at the Carolina Regional Tumor Conference. Raleigh, NC, June 3, 2002. 30. Current Trends in the Management of Locally Advanced Carcinomas of the Head and Neck. Presented at Virginia Regional Cancer Meeting. Virginia Beach, VA, June 4, 2002. NATIONAL PRESENTATIONS – INVITED SPEAKER – Continued 18
    • 31. The Role of Functional Imaging in Radiation Oncology Research Strategies. Presented at Elekta Users Meeting. Nassau, Bahamas, May 31, 2003. 32. Clinical Implementation of an Intensity-Modulated Radiation Therapy Program. Presented at the Annual Meeting of the Atlanta Oncology Associates. Atlanta, GA, August 23, 2003. 33. The Role of Combined Modality Therapy for Locally Advanced Squamous Cell Carcinomas of the Head and Neck. Presented at Grand Rounds of the Cancer Center at Wake Forest University Medical School. October 3, 2003. 34. Combined Modality Management of Head and Neck Cancer. Presented at Educational Symposium at the American Society of Therapeutic Radiation and Oncology Annual Meeting. Salt Lake City, UT, October 19, 2003. 35. Recent Innovations in Radiation Oncology and Paradigm Changes. Presented at the Washington D.C. Veterans Administration Hospital Medical Grand Rounds. Washington, DC, November 5, 2003. 36. Outcome Results of the 1996-1999 Patterns of Care Survey of the National Practice for Patients Receiving Radiation Therapy for Carcinoma of the Esophagus. Presented at the 89th Annual Meeting of Radiological Society of North America Special Focus Session – ASTRO Invited Papers. December 1, 2003. 37. Clinical Applications of Intensity-Modulated Radiation Therapy. Presented at the University of Colorado Radiation Oncology Grand Rounds. December 15, 2003. 38. Post ASTRO Review of the Pertinent Papers in Head and Neck Cancer. Presented at the University of Colorado Annual Review Course. December 15, 2003. 39. The Value of Surgery Following Chemoradiation for Patients with Esophageal Cancer. Presented at the Southern Association of Oncology Annual Meeting. Amelia Island, FL, August 8, 2004. 40. The Role of Tri-Modality in Patients Presenting with Esophageal Cancer. Presented at American Association of Thoracic Surgery Annual Meeting. Toronto, Canada, April 24, 2004. 41. The Use of Concurrent Chemotherapy and Radiation Therapy in the Management of Head and Neck Cancer Patients, Philadelphia Area Radiation Oncology Resident Review, April 28, 2004. Moderator Scientific Session on Coronary and Cerebro-Vascular Radiation. Presented at the 46th Annual Meeting of the American Society for Therapeutic Radiology and Oncology. Atlanta, GA, October 6, 2004. 42. The Evolving Role of Radiation Therapy in the Management of Head and Neck Cancer, Visiting Professor, Hahneman School of Medicine, Drexel University, Department of Radiation Oncology. October 28, 2004. 43. Trimodality Therapy in Esophageal Cancer, Visiting Professor, Weill Medical College of Cornell University, Department of Radiation Oncology, May 19, 2005 44. Future Directions in Esophageal Cancer, Visiting Professor, Emory University School of Medicine, March 24, 2005. LOCAL PRESENTATIONS – INVITED SPEAKER 19
    • 1. Preliminary Results of I125 Implantation for Early Stage Prostate Cancer: The University of Maryland Experience: Presented at the National Cancer Institute Radiation Oncology Grand Rounds. Bethesda, MD, December 9, 1992. 2. The Use of Radiotherapy in the Management of Early Stage Glottic Carcinoma. Presented at Ground Rounds in the Department of Radiation Oncology, University of Maryland. Baltimore, MD, June 1994. 3. Future Trends in the Management of Esophageal Cancers. Presented at Ground Rounds in the Department of Radiation Oncology, University of Maryland. Baltimore, MD, September 1995. 4. The Emerging Role of Brachytherapy in the Treatment of Cholangiocarcinoma. Presented at the Seminars in Liver Diseases at Camden Yards by Invitation of the Liver Center at the University of Maryland Medical Center. Baltimore, MD, April 13, 1996. 5. Review of Current RTOG Head and Neck Protocols. Presented at Ground Rounds in the Hematology/Medical Oncology Conference, University of Maryland Cancer Center. Baltimore, MD, May 6, 1996. 6. Conformal Radiation Therapy. Presented at the University of Maryland Cancer Center Spring Conference on Advances in Cancer Care. Berkeley Springs, WV, June 14-15, 1996. 7. The Role of Brachytherapy in the Prevention of Coronary Artery Restenosis. Presented at Medical Ground Rounds for the School of Medicine, University of Maryland, Department of Medicine. Baltimore, MD, November 5, 1997. 8. Multidisciplinary Treatment of Non-Small Cell Lung Cancer. Presented at the University of Maryland CME Program. Baltimore, MD, October 21, 1999. 9. Advances in the Management of Esophageal Carcinoma. Presented at the Symposium for Thoracic Diseases Multidisciplinary Conference. Baltimore, MD, December 7, 1999. 10. Chemo-Radiation Prior to Surgical Resection for Patients Presenting with Advanced Non-Small Cell Cancers of the Lung. Presented at the Symposium for Thoracic Diseases Multi-Disciplinary Conference. Baltimore, MD, December 7, 1999. 11. Innovations in Radiation Oncology. Presented at the Greenebaum Cancer Center Program in Oncology, Cancer Update 2000. Baltimore, MD, November 17, 2000. 12. Combined Modality Therapy for Patients Presenting with Locally Advanced, Non-Small Cell Lung Cancer. Presented at the Thoracic Diseases in the New Millennium Multidisciplinary Conference. Baltimore, MD, December 7, 2001. 13. The Role of Radiation Therapy in the Management of Patients Presenting with Non-Small Cell Lung Cancer. Presented at The Johns Hopkins Lung Cancer Symposium. Baltimore, MD, November 14, 2003. 14. The Role of Tri-Modality Therapy in the Management of Esophageal Carcinoma. Presented at the Symposium for Thoracic Diseases Multidisciplinary Conference. Baltimore, MD, December 17, 2003. 15. Future Directions in the Management of Head and Neck Cancer Patients. Presented at Oncology Ground Rounds, The Reading Hospital. Reading, VA, September 8, 2004. 16. Results of High Dose Chemotherapy for Esophageal Cancer. Presented at the Symposium for Thoracic Diseases Multidisciplinary Conference. Baltimore, MD, December 3, 2004. 20
    • NATIONAL ORAL PRESENTATIONS 1. Important Predictors of Response Determined by Surgical Stating Prior to Triple Modality Therapy for Esophageal Cancer. Presented to the 39th Annual Scientific Meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO), Orlando, FL, October 19-22, 1997. 2. The Use of Concurrent Chemotherapy and Radiation Prior to Surgical Resection in Patients Presenting with Apical Sulcus Tumors. Presented at the 82nd Annual Meeting of the American Radium Society, London, England, April 1-5, 2000. 3. Clinical Outcomes and Dose Analysis of the Effect of Beta Radiation for the Management of In-Stent Restenosis: Results of the Stents and Radiation Therapy Randomized Trial (START), Presented At the 42nd Annual Scientific Meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO), Boston, MA, October 21-25, 2000. 4. Combination of Adenovirus p16 (INK4A) Gene Therapy and Ionizing Radiation for Squamous Cell Carcinomas of the Head and Neck. Presented at the Head and Neck Poster Discussion session at the 42nd Annual Scientific Meeting of the American society for Therapeutic Radiology and Oncology, October 21-25, 2000. 5. Patient and Personnel Radiation Exposure During Intravascular Brachytherapy: A Single Institutional Experience with Strontium-90 Isotope, presented at the American Heart Association Meeting, New Orleans, LA, November 15, 2000. 6. The Importance of Accurate Lymph Node Assessment Prior to Tri-Modality Therapy in Patients Presenting with Esophageal Cancer, presented at the 83rd Annual American Radium Society, San Diego, CA, April 25-29, 2001. 7. Analysis of Clinical Outcomes from the START and START 40 Trials: The Efficacy of Sr-90 Radiation in the Treatment of Long Lesion In Stent Restenosis. Presented at the 43rd Annual Scientific Meeting of the American Society for Therapeutic Radiology and Oncology, San Francisco, CA, November 7, 2002. 8. The National Standards of Practice for Patients Receiving Radiation Therapy for Carcinoma of the Esophagus: Results of the 1996-1999 Patterns of Care Study. Accepted for Oral Presentation at the 44th Annual Scientific Meeting of the American Society for Therapeutic Radiology and Oncology, New Orleans, LA, October 9, 2002. 9. Outcome Results of the 1996-1999 Patterns of Care Survey of the National Practice for Patients Receiving Radiation Therapy for Carcinoma of the Esophagus. Presented at the 44th Annual Scientific Meeting of the American Society for Therapeutic Radiology and Oncology, Salt Lake City, UT, October 22, 2003. 10. Staging of Esophageal Cancer in Patients Treated with Initial Chemoradiation: Findings of the Patterns of Care Study (PCS). Presented at the 45th Annual Scientific Meeting of the American Society for Therapeutic Radiology and Oncology, Atlanta, GA, October 5, 2004. 11. Long-Term Clinical Follow-Up of the Phase III Randomized Trial (START) Evaluating the Role of Beta Radiation for the Treatment of In-Stent Restensosis. Presented at the 45th Annual Scientific Meeting of the American Society for Therapeutic Radiology and Oncology, Denver, CO, October 17, 2005. 21
    • NATIONAL ORAL PRESENTATIONS – Continued 12. A Phase II Trail Evaluating the Efficacy of Weekly Cetuximab, Paclitaxol, Carboplatin and Daily RT in Esophageal Cancer. Presented at the 46th Annual Scientific Meeting of the American Society for Therapeutic Radiology and Oncology, Philadelphia, PA, November 6, 2006. 13. GCC 0442: A Phase II Trial Evaluating the Efficacy of Weekly Cetuximab, Paclitaxel, Carboplatin and Daily RT in Locally Advanced SCCHN. Presented at the ASTRO’s Multidisciplinary Head and Neck Symposium, Palm Springs, CA, January 18 - 20, 2007. 22